EPL-1410

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameEPL-1410
Drug Alias NameEPL-1410
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitorsTryptophan 2,3-dioxygenase inhibitors
TargetsTryptophan 2,3-dioxygenaseIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEmcure Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEmcure Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A